Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients

References

• Walsh TJ, Anaissie EJ, Denning DW, . Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327–360.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes D, . Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503–535.
   PubMed Web of Science ®Google Scholar
• Boyd AE, Modi S, Howard SJ, . Adverse reactions to voriconazole. Clin Infect Dis 2004; 39: 1241–1244.
   PubMed Web of Science ®Google Scholar
• Denning DW, Ribaud P, Milpied N, . Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002; 34: 563–571.
   PubMed Web of Science ®Google Scholar
• Imhof A, Schaer DJ, Schanz U, Schwarz U. Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring. Swiss Med Wkly 2006; 136: 739–742.
   PubMed Web of Science ®Google Scholar
• Pascual A, Calandra T, Bolay S, . Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 2008; 46: 201–211.
   PubMed Web of Science ®Google Scholar
• Smith J, Safdar N, Knasinski V, . Voriconazole therapeutic drug monitoring. Antimicrob Agents Chemother 2006; 50: 1570–1572.
   PubMed Web of Science ®Google Scholar
• Trifilio S, Ortiz R, Pennick G, . Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2005; 35: 509–513.
   PubMed Web of Science ®Google Scholar
• Miyakis S, van Hal SJ, Ray J, Marriott D. Voriconazole concentrations and outcome of invasive fungal infections. Clin Microbiol Infect 2009; 16: 957–933.
   Google Scholar
• Potoski BA, Brown J. The safety of voriconazole. Clin Infect Dis 2002; 35: 1273–1275.
   PubMed Web of Science ®Google Scholar
• Drusano GL. How does a patient maximally benefit from anti-infective chemotherapy? Clin Infect Dis 2004; 39: 1245–1246.
   Google Scholar
• Trifilio S, Singhal S, Williams S, . Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant 2006; 40: 451–456.
   Google Scholar
• Hope WW, Billaud EM, Lestner J, Denning DW. Therapeutic drug monitoring for triazoles. Curr Opin Infect Dis 2008; 21: 580–586.
   PubMed Web of Science ®Google Scholar
• Smith J, Andes D. Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations. Ther Drug Monit 2008; 30: 167–172.
   PubMed Web of Science ®Google Scholar
• Segal BH, Herbrecht R, Stevens DA, . Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis 2008; 47: 674–683.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (FDA). Guidance for Industry, Bioanalytical Method Validation 2001. Available from the website: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf
   Google Scholar
• Shah VP, Midha KK, Findlay JW, . Bioanalytical method validation – a revisit with a decade of progress. Pharm Res 2000; 17: 1551–1557.
   PubMedGoogle Scholar
• European Medicines Agency (EMEA). Vfend: summary of product characteristics, 2009. Available from the website: http://www.ema.europa.eu/ema/index.jsp?curl = pages/medicines/human/medicines/
   Google Scholar
• Trifilio SM, Yarnold PR, Scheetz MH, . Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation. Antimicrob Agents Chemother 2009; 53: 1793–1796.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Driscoll T, Milligan PA, . Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children. Antimicrob Agents Chemother 2010; 54: 4116–4123.
   PubMed Web of Science ®Google Scholar
• Berge M, Guillemain R, Boussaud V, . Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients. Transpl Infect Dis 2009; 11: 211–219.
   PubMed Web of Science ®Google Scholar
• Trifilio S, Pennick G, Pi J, . Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients. Cancer 2007; 109: 1532–1535.
   PubMed Web of Science ®Google Scholar
• Neely M, Rushing T, Kovacs A, Jelliffe R, Hoffman J. Voriconazole pharmacokinetics and pharmacodynamics in children. Clin Infect Dis 2010; 50: 27–36.
   PubMed Web of Science ®Google Scholar
• Lutsar I, Roffey S, Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis 2003; 37: 728–732.
   PubMed Web of Science ®Google Scholar
• Chhun S, Rey E, Tran A, . Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 852: 223–228.
   PubMed Web of Science ®Google Scholar
• Keevil BG, Newman S, Lockhart S, . Validation of an assay for voriconazole in serum samples using liquid chromatography-tandem mass spectrometry. Ther Drug Monit 2004; 26: 650–657.
   PubMed Web of Science ®Google Scholar
• Langman LJ, Boakye-Agyeman F. Measurement of voriconazole in serum and plasma. Clin Biochem 2007; 40: 1378–1385.
   PubMed Web of Science ®Google Scholar
• Prajapati AM, Patel SA, Patel NJ, Patel DB, Patel SK. Development and validation of reversed-phase column high-performance liquid chromatographic and first-derivative UV spectrophotometric methods for estimation of voriconazole in oral suspension powder. J AOAC Int 2008; 91: 1070–1074.
   Google Scholar
• Vogeser M, Schiel X, Spohrer U. Quantification of voriconazole in plasma by liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 2005; 43: 730–734.
   PubMed Web of Science ®Google Scholar